Market Research Logo

Global Diabetes Devices Market: Industry Analysis & Outlook (2017-2021)

Global Diabetes Devices Market: Industry Analysis & Outlook (2017-2021)

Diabetes, referred to as diabetes mellitus by doctors, is a group of metabolic disorders which abnormally affect the level of sugar (glucose) in blood. Diabetes can either be due to pancreas not producing enough insulin or irresponsiveness of cells of the body to insulin. Insulin is a hormone which regulates the metabolism of carbohydrates, fat and protein by absorbing glucose (sugar) from the blood into fat, liver and skeletal muscles.

Diabetes devices are used in managing and treating diabetes and the market is filled with a vast variety of these devices. These devices can be broadly classified into two categories that include glucose monitoring and insulin pumps. Glucose monitoring devices are further divided into two type: traditional glucose monitoring and continuous glucose monitoring.

The U.S. is a major contributor to the global diabetes device market supported by increased ageing and obese population, better accessibility and favorable reimbursement policies for continuous glucose monitoring systems.

Continuous glucose monitoring was the most significant segment in the growth of global diabetes device market due to technological improvements in monitoring systems and increased recommendations by doctors. This segment is likely to witness a notable growth in future as well.

The global diabetes device market is expected to grow in future with increasing ageing population, obese population, rising spending on diabetes treatment, expanding patient pool suffering from diabetes, increasing disposable income and growing urbanization. Key trends of this market include increasing awareness towards diabetes devices, rising innovations in diabetes devices and adoption of sedentary lifestyle. However, there are some factors which can hinder the market growth including stringent legal norms, high costs and alternative treatments.

The report “Global Diabetes Devices Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., and Europe region along with the global market. The report profiles the key players of the market including Johnson & Johnson, Medtronic plc, Abbott Laboratories and DexCom Inc.


1. Overview
1.1 Diabetes
Table 1: Type of Diabetes
1.2 Symptoms of Diabetes
Table 2: Symptoms of Diabetes
1.3 Diagnosis of Diabetes
1.4 Diabetes Management
1.5 Diabetes Devices
Table 3: Types of Diabetes Device
2. Global Diabetes Devices Market
2.1 Diabetes Devices Market Value Forecast
Table 4: Global Diabetes Devices Market Value Forecast (2016-2021
2.2 Diabetes Devices Market by Type
Table 5: Global Diabetes Devices Market by Type (2016/2021)
2.2.1 Global Glucose Monitoring Devices Market by Value
Table 6: Global Glucose Monitoring Devices Market by Value (2012-2016)
2.2.2 Global Glucose Monitoring Devices Market Value Forecast
Table 7: Global Glucose Monitoring Devices Market Value Forecast (2017-2021)
2.2.3 Global Traditional Glucose Monitoring Market by Value
Table 8: Global Traditional Glucose Monitoring Market by Value (2012-2016)
2.2.4 Global Traditional Glucose Monitoring Market Value Forecast
Table 9: Global Traditional Glucose Monitoring Market Value Forecast (2017-2021)
2.2.5 Global Continuous Glucose Monitoring Market by Value
Table 10: Global Continuous Glucose Monitoring Market by Value (2012-2016)
2.2.6 Global Continuous Glucose Monitoring Market Value Forecast
Table 11: Global Continuous Glucose Monitoring Market Value Forecast (2017-2021)
2.2.7 Global Insulin Pumps Market Value Forecast
Table 12: Global Insulin Pumps Market Value Forecast (2016-2021)
3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Diabetic Population
Table 13: The U.S. Diabetic Population (2013-2016)
3.1.2 The U.S. Diabetic Population Forecast
Table 14: The U.S. Diabetic Population Forecast (2017-2021)
3.1.3 The U.S. Diagnosed Diabetic Population
Table 15: The U.S. Diagnosed Diabetic Population (2013-2016)
3.1.4 The U.S. Diagnosed Diabetic Population Forecast
Table 16: The U.S. Diagnosed Diabetic Population Forecast (2017-2021)
3.1.5 The U.S. Diagnosed Diabetic Population by Type
Table 17: The U.S. Diagnosed Diabetic Population by Type (2016)
3.1.6 The U.S. Continuous Glucose Monitoring Market Forecast
Table 18: The U.S. Continuous Glucose Monitoring Market Forecast (2016-2021)
3.1.7 The U.S. CGM Type 1 Market by Volume
Table 19: The U.S. CGM Type 1 Market by Volume (2013-2016)
3.1.8 The U.S. CGM Type 1 Market Volume Forecast
Table 20: The U.S. CGM Type 1 Market Volume Forecast (2017-2021)
3.1.9 The U.S. CGM Type 1 Market Volume by Patient Type
Table 21: The U.S. CGM Type 1 Market Volume by Patient Type (2013-2016)
3.1.10 The U.S. CGM Type 1 Market Volume Forecast by Type
Table 22: The U.S. CGM Type 1 Market Volume Forecast by Type (2017-2021)
3.1.11 The U.S. Insulin Pump Market by Volume
Table 23: The U.S. Insulin Pump Market by Volume (2013-2016)
3.1.12 The U.S. Insulin Pump Market Volume Forecast
Table 24: The U.S. Insulin Pump Market Volume Forecast (2017-2021)
3.2 Europe
3.2.1 Europe Diabetic Population
Table 25: Europe Diabetic Population (2013-2016)
3.2.2 Europe Diabetic Population Forecast
Table 26: Europe Diabetic Population Forecast (2017-2021)
3.2.3 Europe Diabetic Population by Type
Table 27: Europe Diabetic Population by Type (2016)
3.2.4 Europe CGM Type 1 Market by Volume
Table 28: Europe CGM Type 1 Market by Volume (2013-2016)
3.2.5 Europe CGM Type 1 Market Volume Forecast
Table 29: Europe CGM Type 1 Market Volume Forecast (2017-2021)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Expanding Patient Pool Suffering from Diabetes
Table 30: Global Diabetic Prevalence (2015/2040E)
4.1.2 Increasing Ageing Population
Table 31: Global Ageing Population (2012-2016)
4.1.3 Mounting Obese Population
Table 32: Global Obese Population (2012-2016)
4.1.4 Increasing Life Expectancy
Table 33: Global Life Expectancy at Birth (2012-2016)
4.1.5 Growing Spending on Diabetes Treatment
Table 34: Global Spending on Diabetes Treatment (2015/2040 E)
4.1.6 Rising Urbanization
Table 35: Global Urban Population (2012-2016)
4.1.7 Increasing Disposable Income
Table 36: Global GNI per Capita (2012-2016)
4.2 Key Trends & Developments
4.2.1 Increasing Awareness
4.2.2 Increasing Innovation in Diabetes Devices
4.2.3 Sedentary Lifestyle
4.3 Challenges
4.3.1 Stringent Legal Norms
4.3.2 High Cost and Alternative Treatments
5. Competitive Landscape
5.1 Global Market
5.1.1 Revenue Comparison of Key Players
Table 37: Revenue Comparison of Key Players (2016)
5.1.2 Market Cap of Key Players
Table 38: Market Cap Comparison of Key Players (2016)
5.1.3 Global CGM Market Share by Company
Table 39: Global CGM Market Share by Company (2016/2021)
5.2 The U.S.
5.2.1 The U.S. CGM Market Volume Share by Company
Table 40: The U.S. CGM Market Volume Share by Company (2016/2021)
5.2.2 The U.S. CGM Type 1 Market Volume Share by Company
Table 41: The U.S. CGM Type 1 Market Volume Share by Company (2016/2021)
5.2.3 The U.S. Insulin Pump Market Volume Share by Company
Table 42: The U.S. Insulin Pump Market Volume Share by Company (2016/2021)
6. Company Profiles
6.1 Johnson & Johnson
6.1.1 Business Overview
Table 43: Johnson & Johnson Revenue by Product Segment (2016)
6.1.2 Financial Overview
Table 44: Johnson & Johnson Revenue and Net Earnings (2012-2016)
6.1.3 Business Strategies
Table 45: Johnson & Johnson Research and Development Expenditure (2013-2016)
6.2 Medtronic Plc
6.2.1 Business Overview
Table 46: Medtronic Plc Sales by Segment (2017*)
6.2.2 Financial Overview
Table 47: Medtronic Plc Net Sales and Net Earnings (2012-2017*)
6.2.3 Business Strategies
Table 48: Medtronic R&D Expenditure (2015-2017*)
6.3 Abbott Laboratories
6.3.1 Business Overview
Table 49: Abbott Laboratories Sales by Segment (2016)
6.3.2 Financial Overview
Table 50: Abbott Laboratories Net Sales and Net Earnings (2012-2016)
6.3.3 Business Strategies
Table 51: Abbott Laboratories R&D Expenditure (2014-2016)
6.4 DexCom, Inc.
6.4.1 Business Overview
Table 52: DexCom Revenue by Region (2016)
6.4.2 Financial Overview
Table 53: DexCom Inc. Total Revenue and Net Loss (2012-2016)
6.4.3 Business Strategies
Table 54: DexCom Inc. R&D Expenditure (2014-2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report